Price
CHART BY
Frequently asked questions
What is AtaiBeckley Inc.'s market capitalization?
The market capitalization of AtaiBeckley Inc. is $2.74B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.
What is the Earnings Per Share (EPS) for AtaiBeckley Inc.?
AtaiBeckley Inc.'s Earnings Per Share (EPS) over the trailing twelve months (TTM) is -$2.188. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for AtaiBeckley Inc.'s stock?
Currently, 15 analysts cover AtaiBeckley Inc.'s stock, with a consensus target price of $7.931. Analyst ratings provide insights into the stock's expected performance.
What is AtaiBeckley Inc.'s revenue over the trailing twelve months?
Over the trailing twelve months, AtaiBeckley Inc. reported a revenue of $4.47M.
What is the EBITDA for AtaiBeckley Inc.?
AtaiBeckley Inc.'s Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$145.50M. EBITDA measures the company's overall financial performance.
What is the free cash flow of AtaiBeckley Inc.?
AtaiBeckley Inc. has a free cash flow of -$129.45M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does AtaiBeckley Inc. have, and what sector and industry does it belong to?
AtaiBeckley Inc. employs approximately 117 people. It operates in the Health Care sector, specifically within the Major Pharmaceuticals industry.
What is the free float of AtaiBeckley Inc.'s shares?
The free float of AtaiBeckley Inc. is 302.16M. Free float refers to the number of shares available for public trading, excluding restricted shares.
Financials
- Market Cap
- $2.74B
- EPS (TTM)
- -$2.188
- Free Float
- 302.16M
- Revenue (TTM)
- $4.47M
- EBITDA (TTM)
- -$145.50M
- Free Cashflow (TTM)
- -$129.45M
Pricing
- 1D span
- $7.27$7.381
- 52W span
- $3.27$7.45
Analyst Ratings
The price target is $7.931 and the stock is covered by 15 analysts.
Buy
1
Hold
14
Sell
0
Information
Atai Beckley, Inc. is a clinical-stage biopharmaceutical company focused on developing effective, rapid-acting, and convenient mental health treatments. The company is headquartered in New York, NY.
- Employees
- 117
- Industries
- Major Pharmaceuticals
- Sector
- Health Care
Identifier
- Primary Ticker
- ATAI
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet